169 related articles for article (PubMed ID: 37087107)
41. Monocytic elastase-mediated apolipoprotein-E degradation: Potential involvement of microglial elastase-like proteases in apolipoprotein-E proteolysis in brains with Alzheimers disease.
Suenaga M; Furuta A; Wakabayashi K; Saibara T; Matsunaga Y
Biochim Biophys Acta; 2015 Aug; 1854(8):1010-8. PubMed ID: 25956321
[TBL] [Abstract][Full Text] [Related]
42. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.
Colton CA; Brown CM; Cook D; Needham LK; Xu Q; Czapiga M; Saunders AM; Schmechel DE; Rasheed K; Vitek MP
Neurobiol Aging; 2002; 23(5):777-85. PubMed ID: 12392781
[TBL] [Abstract][Full Text] [Related]
43. APOE-induced microglial activation: an in vitro assay to screen sera from Alzheimer's disease patients and novel therapeutic compounds.
Lombardi VR; García M; Cacabelow R
Methods Find Exp Clin Pharmacol; 1998 Jun; 20(5):377-86. PubMed ID: 9701775
[TBL] [Abstract][Full Text] [Related]
44. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
45.
Ferrari-Souza JP; Lussier FZ; Leffa DT; Therriault J; Tissot C; Bellaver B; Ferreira PCL; Malpetti M; Wang YT; Povala G; Benedet AL; Ashton NJ; Chamoun M; Servaes S; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; O'Brien JT; Rowe JB; Cohen AD; Lopez OL; Tudorascu DL; Karikari TK; Klunk WE; Villemagne VL; Soucy JP; Gauthier S; Souza DO; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
Sci Adv; 2023 Apr; 9(14):eade1474. PubMed ID: 37018391
[TBL] [Abstract][Full Text] [Related]
46. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias.
Martens YA; Zhao N; Liu CC; Kanekiyo T; Yang AJ; Goate AM; Holtzman DM; Bu G
Neuron; 2022 Apr; 110(8):1304-1317. PubMed ID: 35298921
[TBL] [Abstract][Full Text] [Related]
47. Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
Lozupone M; Imbimbo BP; Balducci C; Lo Vecchio F; Bisceglia P; Latino RR; Leone M; Dibello V; Solfrizzi V; Greco A; Daniele A; Watling M; Seripa D; Panza F
Alzheimers Dement; 2023 Jan; 19(1):353-368. PubMed ID: 35900209
[TBL] [Abstract][Full Text] [Related]
48. AD and non-AD mediators of the pathway between the APOE genotype and cognition.
Nichols E; Brickman AM; Casaletto KB; Dams-O'Connor K; George KM; Kumar RG; Palta P; Rabin JS; Satizabal CL; Schneider J; Pa J; La Joie R
Alzheimers Dement; 2023 Jun; 19(6):2508-2519. PubMed ID: 36516004
[TBL] [Abstract][Full Text] [Related]
49. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
50. Apolipoprotein E Polymorphism Impacts White Matter Injury Through Microglial Phagocytosis After Experimental Subarachnoid Hemorrhage.
Li C; Lu P; Zhang L; He Y; Zhang L; Yang L; Zhang F; Kong X; Tao Q; Zhou J; Wu J; Peng T; Xie B; Jiang Y; Peng J
Neuroscience; 2023 Aug; 524():220-232. PubMed ID: 37290684
[TBL] [Abstract][Full Text] [Related]
51. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?
Sparks DL
Ann N Y Acad Sci; 1997 Sep; 826():128-46. PubMed ID: 9329686
[TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
53. ApoE genotype and family history in patients with dementia and cognitively intact spousal controls.
Zintl M; Schmitz G; Hajak G; Klünemann HH
Am J Alzheimers Dis Other Demen; 2009; 24(4):349-52. PubMed ID: 19372276
[TBL] [Abstract][Full Text] [Related]
54. APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.
Parhizkar S; Holtzman DM
Semin Immunol; 2022 Jan; 59():101594. PubMed ID: 35232622
[TBL] [Abstract][Full Text] [Related]
55. Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.
Conejero-Goldberg C; Hyde TM; Chen S; Dreses-Werringloer U; Herman MM; Kleinman JE; Davies P; Goldberg TE
Mol Psychiatry; 2011 Aug; 16(8):836-47. PubMed ID: 20479757
[TBL] [Abstract][Full Text] [Related]
56. Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.
Akram A; Schmeidler J; Katsel P; Hof PR; Haroutunian V
Neurobiol Aging; 2012 Mar; 33(3):628.e1-628.e14. PubMed ID: 21676498
[TBL] [Abstract][Full Text] [Related]
57. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance.
Castellano JM; Kim J; Stewart FR; Jiang H; DeMattos RB; Patterson BW; Fagan AM; Morris JC; Mawuenyega KG; Cruchaga C; Goate AM; Bales KR; Paul SM; Bateman RJ; Holtzman DM
Sci Transl Med; 2011 Jun; 3(89):89ra57. PubMed ID: 21715678
[TBL] [Abstract][Full Text] [Related]
58. Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers.
Hackenhaar FS; Josefsson M; Adolfsson AN; Landfors M; Kauppi K; Hultdin M; Adolfsson R; Degerman S; Pudas S
Alzheimers Res Ther; 2021 Jul; 13(1):130. PubMed ID: 34266503
[TBL] [Abstract][Full Text] [Related]
59. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk.
Borroni B; Grassi M; Costanzi C; Archetti S; Caimi L; Padovani A
Am J Geriatr Psychiatry; 2006 Dec; 14(12):1022-31. PubMed ID: 16956959
[TBL] [Abstract][Full Text] [Related]
60. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples.
Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ
J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
